First Time Loading...

Larimar Therapeutics Inc
NASDAQ:LRMR

Watchlist Manager
Larimar Therapeutics Inc Logo
Larimar Therapeutics Inc
NASDAQ:LRMR
Watchlist
Price: 7.35 USD 6.68% Market Closed
Updated: May 2, 2024

Larimar Therapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Larimar Therapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Larimar Therapeutics Inc
NASDAQ:LRMR
Cash from Financing Activities
$30k
CAGR 3-Years
-93%
CAGR 5-Years
-79%
CAGR 10-Years
-51%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Larimar Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
30k USD

Based on the financial report for Dec 31, 2023, Larimar Therapeutics Inc's Cash from Financing Activities amounts to 30k USD.

What is Larimar Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-51%

Over the last year, the Cash from Financing Activities growth was -100%. The average annual Cash from Financing Activities growth rates for Larimar Therapeutics Inc have been -93% over the past three years , -79% over the past five years , and -51% over the past ten years .